Announcements Trials
Browse Landscape

Phase

Phase 2 116Phase 3 58Phase 1 51Phase 1/2 38Phase 2/3 4Phase NA 3Phase EARLY_PHASE1 2Phase 4 2

Status

Recruiting 1Not yet recruiting 1Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Lymphoid 3

Conditions

Waldenstrom Macroglobulinemia 1Lymphoma, Follicular 1Lymphoma 1

Interventions

Cyclophosphamide 47Rituximab 34Exercise 25fludarabine phosphate 24Methotrexate 24Blood Specimen Collection 23Vincristine 21Cytarabine 21Radiotherapy 20Filgrastim 19Peripheral Blood Stem Cell Transplantation 18Whole-Body Irradiation 17Prednisone 16Melphalan 16Etoposide 16Cyclosporine 16Methods 15Dexamethasone 15Busulfan 15Antilymphocyte Serum 15fludarabine 14Doxorubicin 14Educational Status 13Mycophenolic Acid 12Magnetic Resonance Spectroscopy 11Early Intervention, Educational 11Therapeutics 10Surveys and Questionnaires 9Standard of Care 9Prednisolone 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase NA × Bendamustine Hydrochloride × Lymphoid × Clear all
NCT07126678 2025-08-17

Fixed-Duration Zanubrutinib, Bendamustine, and Obinutuzumab (ZBG) in Treatment-Naïve Advanced Stage Follicular Lymphoma

The First Affiliated Hospital with Nanjing Medical University

Phase NA Recruiting
15 enrolled
Lymphoid

Lymphoma, Follicular

NCT06942507 2025-04-30

BRZ-WM

Peking Union Medical College Hospital

Phase NA Not yet recruiting
104 enrolled
Lymphoid

Waldenstrom Macroglobulinemia

NCT05813132 2024-09-05

BeEAM Versus CEM in Lymphoma Patients as a Conditioning Regimen Before Autologous Hematopoietic Cell Transplantation

Damanhour University

Phase NA Completed
58 enrolled
Lymphoid

Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡